↑ 疾患リストへ ← 戻る

 155. ランドウ・クレフナー症候群 [臨床試験数:1,薬物数:2(DrugBank:2),標的遺伝子数:18,標的パスウェイ数:3] 

Searched query = "Acquired aphasia with convulsive disorder", "Landau-Kleffner syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 11/21/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.

Search in Page    e.g. "Phase 3", "Not recruiting", "Japan"    Synonyms (DrugBank) were also searched for.
No.TrialIDDate_
enrollement
Last_Refreshed_
on
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02904265September 201622 October 2019Efficacy Study of Acetazolamide Versus Diazepam in Continuous Spike and Wave/Landau-Kleffner SyndromeNon-inferiority Prospective Randomized Trial of Acetazolamide Versus Diazepam in Patients With Continuous Spike and Wave in Sleep (CSWS)/Landau Kleffner Syndrome (LKS)Landau-Kleffner Syndrome;Status Epilepticus, ElectrographicDrug: Diazepam;Drug: AcetazolamideMayo ClinicNot recruiting3 Years12 YearsAll3Phase 2/Phase 3United States